ABT-263 and Rapamycin Act Cooperatively to Kill Lymphoma Cells in Vitro and in Vivo

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-08-0268
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

ABT-263 Induces G1/G0-Phase Arrest, Apoptosis and Autophagy in Human Esophageal Cancer Cells in Vitro

Acta Pharmacologica Sinica
MedicinePharmacology
2017English

Flavopiridol Enhances ABT-199 Sensitivity in Unfavourable-Risk Multiple Myeloma Cells in Vitro and in Vivo

British Journal of Cancer
Cancer ResearchOncology
2017English

Human Pluripotent Stem Cells and Derived Neuroprogenitors Display Differential Degrees of Susceptibility to BH3 Mimetics ABT-263, WEHI-539 and ABT-199

PLoS ONE
Multidisciplinary
2016English

Norcantharidin Enhances ABT-263-mediated Anticancer Activity in Neuroblastoma Cells by Upregulation of Noxa

Oncology Reports
MedicineCancer ResearchOncology
2014English

Carfilzomib Interacts Synergistically With Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Enhanced Antitumor Activity of 3-Bromopyruvate in Combination With Rapamycin in Vivo and in Vitro

Cancer Prevention Research
MedicineCancer ResearchOncology
2015English

Pitavastatin Suppressed Liver Cancer Cells in Vitro and in Vivo

OncoTargets and Therapy
OncologyPharmacology
2016English

Burkitt's Lymphoma: Differential Killing of Epstein-Barr Virus (EBV) (+) and EBV(-) Burkitt Lymphoma Cells in Vitro and Dose-Dependent Lytic Induction by Bortezomib in Vivo

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2009English

Fc Optimization of Therapeutic Antibodies Enhances Their Ability to Kill Tumor Cells in Vitro and Controls Tumor Expansion in Vivo via Low-Affinity Activating Fc Receptors

Cancer Research
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy